Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Autoimmune Disorders

  Free Subscription


08.04.2019

1 Acta Neurol Scand
1 Am J Kidney Dis
2 Ann Neurol
1 Brain
1 Curr Opin Immunol
1 Diabetes
1 J Immunol
2 J Neuroimmunol
1 J Pediatr
2 J Rheumatol
1 Kidney Int
5 Mult Scler
2 Nat Rev Neurol
1 Neurology
6 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Acta Neurol Scand

  1. SEDANO MJ, Orizaola P, Gallardo E, Garcia A, et al
    A unicenter, prospective study of Guillain-Barre syndrome in Spain.
    Acta Neurol Scand. 2019 Mar 31. doi: 10.1111/ane.13092.
    PubMed     Text format     Abstract available


    Am J Kidney Dis

  2. RUGGENENTI P, Daina E, Gennarini A, Carrara C, et al
    C5 Convertase Blockade in Membranoproliferative Glomerulonephritis: A Single-Arm Clinical Trial.
    Am J Kidney Dis. 2019 Mar 28. pii: S0272-6386(19)30100.
    PubMed     Text format     Abstract available


    Ann Neurol

  3. HERRANZ E, Hooker JM, Izquierdo-Garcia D, Loggia ML, et al
    11 C-PBR28 increase in multiple sclerosis reflects neuroinflammation.
    Ann Neurol. 2016 Dec 29. doi: 10.1002/ana.24865.
    PubMed     Text format    

  4. RAFFEL J, Sridharan S, Nicholas R
    [11 C]PBR-28 PET in multiple sclerosis: Neuroinflammation or otherwise?
    Ann Neurol. 2016 Dec 26. doi: 10.1002/ana.24853.
    PubMed     Text format    


    Brain

  5. WEKERLE H
    Secondary progressive multiple sclerosis and the gut-brain axis.
    Brain. 2019;142:838-840.
    PubMed     Text format    


    Curr Opin Immunol

  6. BOUDREAU JE, Hsu KC
    Natural killer cell education in human health and disease.
    Curr Opin Immunol. 2018;50:102-111.
    PubMed     Text format     Abstract available


    Diabetes

  7. WIEDE F, Brodnicki T, Goh PK, Leong YA, et al
    T Cell-Specific PTPN2-Deficiency in NOD Mice Accelerates the Development of Type 1 Diabetes and Autoimmune Co-Morbidities.
    Diabetes. 2019 Apr 1. pii: db18-1362. doi: 10.2337/db18-1362.
    PubMed     Text format     Abstract available


    J Immunol

  8. MCLACHLAN SM, Aliesky HA, Rapoport B
    Nanoparticles Bearing TSH Receptor Protein and a Tolerogenic Molecule Do Not Induce Immune Tolerance but Exacerbate Thyroid Autoimmunity in hTSHR/NOD.H2(h4) Mice.
    J Immunol. 2019 Apr 3. pii: jimmunol.1900038. doi: 10.4049/jimmunol.1900038.
    PubMed     Text format     Abstract available


    J Neuroimmunol

  9. SCHLIFFKE S, Carambia A, Akyuz N, Thiele B, et al
    T-cell repertoire profiling by next-generation sequencing reveals tissue migration dynamics of TRBV13-family clonotypes in a common experimental autoimmune encephalomyelitis mouse model.
    J Neuroimmunol. 2019;332:49-56.
    PubMed     Text format     Abstract available

  10. XU H, Zhang M, Li XL, Li H, et al
    Corrigendum to: "low and high doses of ursolic acid ameliorate experimental autoimmune myasthenia gravis through different pathways" [Journal of Neuroimmunology 281 (2015) 61-67].
    J Neuroimmunol. 2019;330:181-183.
    PubMed     Text format    


    J Pediatr

  11. O'BRIEN SH, Despotovic JM, Neunert CE
    Intravenous Immunoglobulin Versus Anti-D Immunoglobulin: When Better Treatment May Not Be the Best Treatment.
    J Pediatr. 2019;204:11-13.
    PubMed     Text format    


    J Rheumatol

  12. MILLS BS, Dao KH, Tecson KM, Fishman E, et al
    Perceptions of Pregnancy and Lactation from the Pregnancy and Lactation Autoimmune Network (PLAN) Registry.
    J Rheumatol. 2019 Apr 1. pii: jrheum.181067. doi: 10.3899/jrheum.181067.
    PubMed     Text format     Abstract available

  13. BESSE MC, Collercandy N, Diot E
    Gynecologic Vasculitis: Positron Emission Tomography-Computed Tomography Contribution in a Rare Localization of Giant Cell Arteritis.
    J Rheumatol. 2019;46:439.
    PubMed     Text format    


    Kidney Int

  14. CRAIG JC
    Interpreting trial results-time for confidence and magnitude and not P values please.
    Kidney Int. 2019;95:28-30.
    PubMed     Text format     Abstract available


    Mult Scler

  15. BARTELS F, Nobis K, Cooper G, Wendel E, et al
    Childhood multiple sclerosis is associated with reduced brain volumes at first clinical presentation and brain growth failure.
    Mult Scler. 2019 Apr 4:1352458519829698. doi: 10.1177/1352458519829698.
    PubMed     Text format     Abstract available

  16. BANWELL B
    Are children with multiple sclerosis really "old" adults.
    Mult Scler. 2019 Apr 4:1352458519841505. doi: 10.1177/1352458519841505.
    PubMed     Text format    

  17. KIRA JI
    Reply to letter to the editor: Dimethyl fumarate for patients with neuromyelitis optica spectrum disorder by Pitarokoili and Gold.
    Mult Scler. 2018;24:366-367.
    PubMed     Text format    

  18. YAMOUT BI, Zeineddine MM
    Letter to the editor.
    Mult Scler. 2018;24:363.
    PubMed     Text format    

  19. PITAROKOILI K, Gold R
    Dimethyl fumarate for patients with neuromyelitis optica spectrum disorder.
    Mult Scler. 2018;24:364-365.
    PubMed     Text format    


    Nat Rev Neurol

  20. ROTSTEIN D, Montalban X
    Reaching an evidence-based prognosis for personalized treatment of multiple sclerosis.
    Nat Rev Neurol. 2019 Apr 2. pii: 10.1038/s41582-019-0170.
    PubMed     Text format     Abstract available

  21. TROJANO M, Amato MP
    Author Correction: Progress in multiple sclerosis - from diagnosis to therapy.
    Nat Rev Neurol. 2019 Apr 1. pii: 10.1038/s41582-019-0179.
    PubMed     Text format     Abstract available


    Neurology

  22. CORTESE M, Chitnis T, Ascherio A, Munger KL, et al
    Total intake of different minerals and the risk of multiple sclerosis.
    Neurology. 2019 Apr 3. pii: WNL.0000000000006800.
    PubMed     Text format     Abstract available


    PLoS One

  23. CHOI JY, Chung JE, Park JH, Cho YS, et al
    Surveillance of adverse drug events associated with etanercept prescribed for juvenile idiopathic arthritis in a single center up to 9-years: A retrospective observational study.
    PLoS One. 2018;13:e0204573.
    PubMed     Text format     Abstract available

  24. GARAU M, Cabrera J, Ottati G, Caorsi H, et al
    Temporal trends in biopsy proven glomerular disease in Uruguay, 1990-2014.
    PLoS One. 2018;13:e0206637.
    PubMed     Text format     Abstract available

  25. NOCITI V, Santoro M, Quaranta D, Losavio FA, et al
    BDNF rs6265 polymorphism methylation in Multiple Sclerosis: A possible marker of disease progression.
    PLoS One. 2018;13:e0206140.
    PubMed     Text format     Abstract available

  26. DIVINO V, Mallick R, DeKoven M, Krishnarajah G, et al
    The economic burden of CIDP in the United States: A case-control study.
    PLoS One. 2018;13:e0206205.
    PubMed     Text format     Abstract available

  27. MARTINEZ VALENZUELA L, Draibe J, Quero Ramos M, Fulladosa Oliveras X, et al
    Calprotectin as a smoldering activity detection tool and renal prognosis biomarker in ANCA associated vasculitis.
    PLoS One. 2018;13:e0205982.
    PubMed     Text format     Abstract available

  28. PENG Y
    B cell responses to apoptotic cells in MFG-E8-/- mice.
    PLoS One. 2018;13:e0205172.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Autoimmune Disorders is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: